APN-122597

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAPN-122597

Drug Alias NameAPN-122597

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionEphrin type-A receptor 2 antagonistsCD3 T-cell engagers

TargetsEphrin type-A receptor 2T cell surface glycoprotein CD3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAtreca Inc

China Registration ClassN/A

Develop Information

Active CompaniesAtreca Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A